Dark Forest Capital Management LP Intercept Pharmaceuticals, Inc. Transaction History

Dark Forest Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$9.17 - $19.29 $74,552 - $156,827	8,130 Added 394.09%	10,193 $112,000
Q1 2023 May 12, 2023	BUY	$12.53 - $21.71 $25,849 - $44,787	2,063 New	2,063 $27,000
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $213 - $372	19 New	19 $0
Q1 2022 May 13, 2022	SELL	$13.37 - $17.79 $40 - $53	-3 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$14.28 - $19.53 $1,884 - $2,577	-132 Reduced 97.78%	3 $0
Q3 2021 Nov 12, 2021	BUY	$12.99 - $20.47 $1,753 - $2,763	135 New	135 $2,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.